欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2006, Vol. 11 ›› Issue (8): 898-901.

• 研究原著 • 上一篇    下一篇

乳腺癌组织中胰岛素样生长因子结合蛋白-2 的表达及其与雌激素受体、孕激素受体相关性的研究

何杨, 吉兆宁, 王潞   

  1. 皖南医学院弋矶山医院肿瘤内科, 芜湖 241000, 安徽
  • 收稿日期:2006-04-18 修回日期:2006-05-30 出版日期:2006-08-26 发布日期:2020-11-05
  • 通讯作者: 吉兆宁,男, 博士, 硕士生导师, 研究方向:抗肿瘤药物的药理。
  • 作者简介:何杨, 女, 硕士研究生, 研究方向:肿瘤的生物与化学防治。Tel:0553-3398574  E-mail:heyang418@sina.com

Expression of IGFBP-2 and its correlation with estrogen receptor, progesterone receptor in breast cancer

HE Yang, JI Zhao-ning, WANG Lu   

  1. Department of Oncology , Wannan Medical College, Wuhu 241000 , Anhui , China
  • Received:2006-04-18 Revised:2006-05-30 Online:2006-08-26 Published:2020-11-05

摘要: 目的 研究胰岛素样生长因子结合蛋白-2(IGFBP-2) 在乳腺癌组织中的表达, 探讨其与乳腺癌临床病理学特征的关系及与雌激素受体(ER) 、孕激素受体(PR) 的相关性。方法 用免疫组织化学SP法检测42 例乳腺癌患者肿瘤组织中IGFBP-2 和ER、PR 的表达水平。结果 在不同大小原发灶、年龄和类型乳腺癌组织中IGFBP-2 的表达率无显著差异(P>0.05);IGFBP-2 在有淋巴结转移乳腺癌中的表达显著高于无淋巴结转移乳腺癌(P<0.05) 。IGFBP-2 与ER 在乳腺癌中的表达呈中度正相关(P<0.01, rs =0.486);与PR 在乳腺癌中表达无明显相关性(P>0.05, rs =0.271) 。结论 IGFBP-2 的表达在乳腺癌的发展和侵袭转移可能起重要作用, 并与ER 在乳腺癌中的表达呈正相关, 提示IGFBP-2 的高表达可能是乳腺癌预后不良的指标之一, 对乳腺癌的临床治疗有一定的指导作用。

关键词: 乳腺癌, 胰岛素样生长因子受体结合蛋白-2, 雌激素受体, 孕激素受体

Abstract: AIM: To investigate the expression of insulin-like growth factor binding protein-2 (IGFBP-2) in breast cancer and its connection with clinical pathological characteristics of breast cancer as well as the correlation between IGFBP-2 expression and estrogen receptor (ER) and progesterone receptor (PR).METHODS: Examined the expression of IGFBP-2, ER and PR in 42 cases of the breast carcinomas with the immunohistochemical technique(S-Pmethod).RESULTS: There was no significant difference between the primary tumor extension, age and category in breast cancer (P>0.05);the positive percentage of IGFBP-2 was statistically higher in breast cancer with metastasis in lymph node than those without metastasis in lymph node (P<0.05).The expression of IGFBP-2 in breast cancer is midrange positive correlation with that of ER (P<0.01, rs =0.486) , and it is not connected with expression of PR in breast cancer (P>0.05, rs =0.271).CONCLUSION: The expression of IGFBP-2 may play an important role in the progression,invasion and metastasis of breast cancer, and there is a positive correlation between the expression of IGFBP-2 and ER in breast cancer.It demonstrates that over expression of IGFBP-2 may be a reference to evaluate unfavourable prognosis of breast cancer.

Key words: breast cancer, insulin-like growth factor binding protein-2, estrogen receptor, progesterone receptor

中图分类号: